Mortality risk factors in patients with SARS-CoV-2 infection and atrial fibrillation: Data from the SEMI-COVID-19 registry
Gómez et al.,
Mortality risk factors in patients with SARS-CoV-2 infection and atrial fibrillation: Data from the..,
Medicina Clínica (English Edition), doi:10.1016/j.medcle.2022.01.020
Retrospective 1,799 hospitalized COVID-19 patients with atrial fibrillation in Spain, showing lower mortality with HCQ treatment in unadjusted results.
This study is excluded in the after exclusion results of meta
analysis:
unadjusted results with no group details.
risk of death, 35.8% lower, RR 0.64, p < 0.001, treatment 500 of 1,378 (36.3%), control 238 of 421 (56.5%), NNT 4.9.
|
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
|
Gómez et al., 13 Oct 2022, retrospective, Spain, peer-reviewed, 10 authors, study period 1 March, 2020 - 1 October, 2020.
Contact:
manuel.mendez@salud.madrid.org.
Abstract: Journal Pre-proof
Mortality risk factors in patients with SARS-CoV-2 infection and atrial
fibrillation: Data from the SEMI-COVID-19 registry
Javier Azaña Gómez, Luis M. Pérez-Belmonte, Manuel
Rubio-Rivas, Jose Bascuñana, Raul Quirós-López, Maria Luisa
Taboada Martı́nez, Esther Montero Hernandez, Fernando
Roque-Rojas, Manuel Méndez-Bailón, Ricardo Gómez-Huelgas, en
nombre del grupo SEMI-COVID-19
PII:
S2387-0206(22)00502-2
DOI:
https://doi.org/10.1016/j.medcle.2022.01.020
Reference:
MEDCLE 5908
To appear in:
Medicina Clı́nica (English Edition)
Received Date:
23 October 2021
Accepted Date:
10 January 2022
Please cite this article as: { doi: https://doi.org/
This is a PDF file of an article that has undergone enhancements after acceptance, such as
the addition of a cover page and metadata, and formatting for readability, but it is not yet the
definitive version of record. This version will undergo additional copyediting, typesetting and
review before it is published in its final form, but we are providing this version to give early
visibility of the article. Please note that, during the production process, errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal
pertain.
© 2020 Published by Elsevier.
MEDCLI 5908
Original
Mortality risk factors in patients with SARS-CoV-2 infection and atrial fibrillation: Data from the
SEMI-COVID-19 registry
ro
of
Factores de riesgo de mortalidad en pacientes con infección por SARS-CoV-2 y afectos de
fibrilación auricular: datos del registro SEMI-COVID-19
Javier Azaña Gómez MD, 1, Luis M. Pérez-Belmonte, MD, PhD2, Manuel Rubio-Rivas MD3, Jose
Bascuñana MD 4, Raul Quirós-López MD 5 , Maria Luisa Taboada Martínez MD 6, Esther
Montero Hernandez 7, Fernando Roque-Rojas 8, Manuel Méndez-Bailón*, MD, PhD1 ¶
Ricardo Gómez-Huelgas, MD, PhD2 en nombre del grupo SEMI-COVID-19**.
-p
1 Servicio de Medicina Interna, Hospital Clínico San Carlos, Universidad Complutense de
Madrid, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid,
España.
re
2 Servicio de Medicina Interna, Hospital Regional Universitario de Málaga, Instituto de
Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga (UMA)( Málaga), España.
lP
3 Servicio de Medicina Interna. Hospital Universitario de Bellvitge-IDIBELL. L'Hospitalet de
Llobregat (Barcelona), España
4 Servicio de Medicina Interna. Hospital Universitario 12 de Octubre. Madrid, España
na
5. Servicio de Medicina Interna. Hospital Universitario Costa del Sol. Marbella (Málaga), España
6 Servicio de Medicina Interna. Hospital Universitario de Cabueñes. Gijón (Asturias),España
ur
7 Servicio de Medicina Interna. Hospital Universitario Puerta de Hierro. Majadahonda
(Madrid), España
8 Servicio de Medicina Interna. Hospital Universitario Infanta Cristina. Parla (Madrid), España
Jo
*Autor para correspondencia:
Manuel Méndez Bailón. Dirección: Servicio de Medicina Interna, Hospital Universitario Clínico
San Carlos. Calle del Profesor Martín Lagos, s/n, 28040, Madrid, España. Teléfono: 91 3303000.
E-mail: manuel.mendez@salud.madrid.org
¶ Los doctores Méndez-Bailón y Gómez-Huelgas comparten la autoría final.
1
** La lista completa de miembros del grupo SEMI-COVID-19 aparecen relacionados en el
anexo.
RESUMEN
Introducción: La fibrilación auricular y las comorbilidades asociadas a ella suponen un factor de
riesgo de mortalidad, morbilidad y desarrollo de complicaciones en..
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are complementary. All practical, effective, and safe means should
be used based on risk/benefit analysis. No treatment, vaccine, or intervention
is 100% available and effective for all current and future variants. We do not
provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation.
FLCCC and
WCH
provide treatment protocols.
Submit